HistoRx - About the company
HistoRx is an acquired company based in Branford (United States), founded in 2001. It operates as a Biomarker solutions and clinical trial testing services for drug development. HistoRx has raised $13.3M in funding from Brook Venture Partners. The company has 114 active competitors, including 30 funded and 15 that have exited. Its top competitors include companies like Bit.bio, Cellply and CytoTronics.
Company Details
Biomarker solutions and clinical trial testing services for drug development. We are a testing laboratory designing innovative biomarker solutions and customized validations for clinical development. Our technology-agnostic approach ensures the right answers using genomic, flow, digital pathology, and ligand binding analysis methods across drug development and manufacturing. We deliver impactful results, informing treatment decisions, establishing pharmacodynamic understanding, and determining manufacturing product suitability. We partner with clients, offering targeted solutions, end-to-end support, and quality oversight to mitigate regulatory risks. Our expertise helps determine the best platform for intended use, aligning analytical methods with patient populations. We offer services in the therapeutic areas.
- Website
- historx.com
Key Metrics
Founded Year
2001
Location
Branford, United States
Stage
Acquired
Total Funding
$13.3M in 5 rounds
Latest Funding Round
Investors
Ranked
12th among 114 active competitors
Exit Details
Acquired by Genoptix (Sep 09, 2012)
HistoRx's acquisition details
HistoRx got acquired by Genoptix on Sep 09, 2012.
Click here to take a look at HistoRx's acquisition in detail
Sign up to download HistoRx's company profile
HistoRx's funding and investors
HistoRx has raised a total funding of $13.3M over 5 rounds. Its first funding round was on Sep 14, 2004. HistoRx has 8 institutional investors.
Here is the list of recent funding rounds of HistoRx:
Filter this list
Filter this listDate of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
May 25, 2011 | 9612196 | Series B | 9974287 | 5316542 | 3711418 | 7708080 |
Dec 04, 2009 | 2445012 | Series B | 2516831 | 3760352 | 7478249 | 2466427 |
Oct 28, 2008 | 8673973 | Grant (prize money) | 6203572 | 9316946 | 2757078 |
Access funding benchmarks and valuations. Sign up today!View details of HistoRx's funding rounds and investors
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
HistoRx's Competitors and alternates
Top competitors of HistoRx include Bit.bio, Cellply and CytoTronics. Here is the list of Top 10 competitors of HistoRx, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Bit.bio 2016, Cambridge (United Kingdom), Series C | Manufacturer of programmed human cells for research and drug discovery | $266M | 68/100 | |
2nd | Developer of in-vitro diagnostic products for the detection of cancer | $16.4M | 60/100 | ||
3rd |  CytoTronics 2015, Boston (United States), Series A | Developer of cell-based assays for drug discovery | $22.8M | 56/100 | |
4th | Kiyatec 2005, Pendleton (United States), Series C | Develops 3D phenotypic cell-based assays and diagnostic solutions for prediction of patients’ response to cancer drug treatment | $29.5M | 55/100 | |
5th | Developer of 3D cell culture products for drug discovery | $4.1M | 49/100 | ||
6th | Pelago Bioscience 2013, Solna (Sweden), Seed | Assay services for use in the determination and quantification of drug-target interactions | - | 48/100 | |
7th |  Cytotheryx 2018, Rochester (United States), Series A | Developer of human hepatocytes for research and clinical applications | $60M | 47/100 | |
8th | StemBioSys 2010, San Antonio (United States), Series A | Cell culture technology company advancing regenerative medicine and drug discovery | $14.5M | 45/100 | |
9th |  Nanocrine 2018, Frederick (United States), Seed | Provider of a cell analysis and drug design tool for researchers | $300K | 43/100 | |
10th | SK Plasma 1970, Seongnam-si (South Korea), Funding Raised | Manufactures plasma derivatives | - | 42/100 | |
12th | HistoRx 2001, Branford (United States), Acquired | Biomarker solutions and clinical trial testing services for drug development | $13.3M | 41/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on HistoRx's competitors? Click here to see the top ones
HistoRx's Investments and acquisitions
HistoRx has made no investments or acquisitions yet.
Reports related to HistoRx
Here is the latest report on HistoRx's sector:
News related to HistoRx
•
•
•
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about HistoRx
Explore our recently published companies
- Wisdom Square Technologies - New Hyde Park based, 2008 founded, Unfunded company
- Fruverpack - Almoradi based, 1992 founded, Unfunded company
- AERA - Bouxwiller based, 1979 founded, Unfunded company
- Divine Hindu - Ujjain based, 2023 founded, Unfunded company
- Globaldigitalpartner.com - 2013 founded, Unfunded company
- OROK - Bourgoin Jallieu based, 2018 founded, Deadpooled company
